US 11897945
Methods of treating allergy using anti-Bet v 1 antibodies
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11897945 (Methods of treating allergy using anti-Bet v 1 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/395